{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:56:47Z","timestamp":1791982607803,"version":"4.4.0"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T00:00:00Z","timestamp":1706832000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,2,2]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Serum galactomannan (GM) and \u03b2-D-glucan (BG) are known markers of invasive aspergillosis (IA). The aim of this meta-analysis was to evaluate the efficiency of serum GM and BG as diagnostic markers of symptomatic IA infection and compare the performance of the combined tests with that of either test individually.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A literature search was carried out using PubMed, Web of Science, and EMBASE databases to include relevant studies published in English up to May 2023. The quality assessment was performed using Review Manager 5.3 software. A bivariate model was applied to pool diagnostic parameters using Stata 14.0 software. We used Cochrane <jats:italic toggle=\"yes\">I<\/jats:italic>\n                                 <jats:sup>2<\/jats:sup> index to assess heterogeneity and identify the potential source of heterogeneity by meta-regression. Paired <jats:italic toggle=\"yes\">t<\/jats:italic> tests were used to compare the value of GM and BG for IA diagnosis when used in combination or alone.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Sixteen studies were eligible for inclusion in the meta-analysis. For proven or probable IA, serum GM and BG yielded a pooled sensitivity of 0.53 (95% CI 0.40\u20130.66) vs 0.72 (95% CI 0.61\u20130.81) and a pooled specificity of 0.94 (95% CI 0.91\u20130.97) vs 0.82 (95% CI 0.73\u20130.88). The area under the curve (AUC) of ROC was 0.90 (95% CI 0.87\u20130.92) vs 0.83 (95% CI 0.80\u20130.86) for all studies. The pooled sensitivity and specificity for IA diagnosis by combined GM and BG assays (GM\/BG) were 0.84 (95% CI 0.69\u20130.86) and 0.76 (95% CI 0.69\u20130.81), respectively. The sensitivity of the combined GM\/BG test to diagnose IA was higher than of the GM or BG test alone.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Serum GM and BG tests had a relatively high accuracy for IA diagnosis in suspected patients. The diagnostic accuracy of both assays is comparable, and the diagnostic sensitivity is further improved by the combined detection of the 2 markers.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000037067","type":"journal-article","created":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T21:02:08Z","timestamp":1706907728000},"page":"e37067","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":28,"title":["Diagnostic performance of serum galactomannan and \u03b2-D-glucan for invasive aspergillosis in suspected patients: A meta-analysis"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0689-5795","authenticated-orcid":false,"given":"Qian-Yi","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Transfusion, Nanchong Central Hospital Second Clinical School of North Sichuan Medical College: Nanchong Central Hospital Affiliated to North Sichuan Medical College, Nanchong City, Sichuan Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-Cheng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Nanchong Central Hospital Second Clinical School of North Sichuan Medical College: Nanchong Central Hospital Affiliated to North Sichuan Medical College, Nanchong City, Sichuan Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Rui","family":"Yue","sequence":"additional","affiliation":[{"name":"Department of Transfusion, Nanchong Central Hospital Second Clinical School of North Sichuan Medical College: Nanchong Central Hospital Affiliated to North Sichuan Medical College, Nanchong City, Sichuan Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1128\/CMR.00055-08","article-title":"Pathogenesis of Aspergillus fumigatus in invasive aspergillosis.","volume":"22","author":"Dagenais","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.healun.2018.06.008","article-title":"Clinical risk factors for invasive aspergillosis in lung transplant recipients: results of an international cohort study.","volume":"37","author":"Aguilar","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1183\/09031936.02.00256102","article-title":"Diagnosis and treatment of invasive pulmonary aspergillosis in neutropenic patients.","volume":"19","author":"Reichenberger","year":"2002","journal-title":"Eur Respir J"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1439-0507.2011.02044.x","article-title":"Invasive fungal infections in the intensive care unit: a multicentre, prospective, observational study in Italy (2006-2008).","volume":"55","author":"Tortorano","year":"2012","journal-title":"Mycoses"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.3324\/haematol.2013.094359","article-title":"Early diagnosis of invasive pulmonary aspergillosis in hematologic patients: an opportunity to improve the outcome.","volume":"98","author":"Nucci","year":"2013","journal-title":"Haematologica"},{"issue":"suppl_1","key":"R6-20250504","doi-asserted-by":"crossref","first-page":"i19","DOI":"10.1093\/jac\/dkx030","article-title":"Early diagnosis of invasive mould infections and disease.","volume":"72","author":"Lamoth","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/QCO.0b013e328328cfff","article-title":"New therapies for fungal pneumonia.","volume":"22","author":"Maertens","year":"2009","journal-title":"Curr Opin Infect Dis"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1439-0507.2007.01375.x","article-title":"Advances in the serological diagnosis of invasive aspergillus infections in patients with haematological disorders.","volume":"50","author":"Maertens","year":"2007","journal-title":"Mycoses"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1473-3099(05)70238-3","article-title":"Laboratory diagnosis of invasive aspergillosis.","volume":"5","author":"Hope","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1128\/jcm.33.12.3115-3118.1995","article-title":"Plasma (1-->3)-beta-D-glucan and fungal antigenemia in patients with candidemia, aspergillosis, and cryptococcosis.","volume":"33","author":"Miyazaki","year":"1995","journal-title":"J Clin Microbiol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group.","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1086\/323335","article-title":"Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.","volume":"34","author":"Ascioglu","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1469-0691.2010.03357.x","article-title":"A prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under intensive care: comparison with the diagnostic performance of galactomannan and of (1\u21923)-\u03b2-d-glucan chromogenic assay in serum samples.","volume":"17","author":"Acosta","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3855\/jidc.2110","article-title":"Diagnostic potential of nested PCR, galactomannan EIA, and beta-D-glucan for invasive aspergillosis in pediatric patients.","volume":"6","author":"Badiee","year":"2012","journal-title":"J Infect Dev Ctries"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jcrc.2018.07.001","article-title":"Detection of invasive pulmonary aspergillosis in critically ill patients by combined use of conventional culture, galactomannan, 1-3-beta-D-glucan and aspergillus specific nested polymerase chain reaction in a prospective pilot study.","volume":"47","author":"Boch","year":"2018","journal-title":"J Crit Care"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.2169\/internalmedicine.53.2381","article-title":"Diagnostic value of the serum galactomannan and (1, 3)-\u03b2-D-glucan assays for invasive pulmonary aspergillosis in non-neutropenic patients.","volume":"53","author":"Cai","year":"2014","journal-title":"Intern Med"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/myc.12765","article-title":"Diagnostic value of serum galactomannan, (1,3)-\u03b2-d-glucan, and Aspergillus fumigatus-specific IgA and IgG assays for invasive pulmonary aspergillosis in non-neutropenic patients.","volume":"61","author":"Dobias","year":"2018","journal-title":"Mycoses"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1128\/JCM.00506-08","article-title":"Utility of galactomannan enzyme immunoassay and (1,3) beta-D-glucan in diagnosis of invasive fungal infections: low sensitivity for Aspergillus fumigatus infection in hematologic malignancy patients.","volume":"47","author":"Hachem","year":"2009","journal-title":"J Clin Microbiol"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1128\/JCM.00467-14","article-title":"Performance of galactomannan, beta-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis.","volume":"52","author":"Hoenigl","year":"2014","journal-title":"J Clin Microbiol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jcrc.2016.06.026","article-title":"Comparison of 1,3-\u03b2-d-glucan with galactomannan in serum and bronchoalveolar fluid for the detection of Aspergillus species in immunosuppressed mechanical ventilated critically ill patients.","volume":"36","author":"Lahmer","year":"2016","journal-title":"J Crit Care"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s11046-016-0011-x","article-title":"Comparison of serum galactomannan and 1,3-Beta-D-glucan determination for early detection of invasive pulmonary aspergillosis in critically Ill patients with hematological malignancies and septic shock.","volume":"181","author":"Lahmer","year":"2016","journal-title":"Mycopathologia"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1128\/JCM.43.1.299-305.2005","article-title":"Contribution of (1->3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan.","volume":"43","author":"Pazos","year":"2005","journal-title":"J Clin Microbiol"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s15010-015-0849-8","article-title":"Evaluation of serum (1-3)-\u03b2-D-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors.","volume":"44","author":"Pini","year":"2016","journal-title":"Infection"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1128\/JCM.03567-13","article-title":"Use and limits of (1-3)-\u03b2-d-glucan assay (Fungitell), compared to galactomannan determination (Platelia Aspergillus), for diagnosis of invasive aspergillosis.","volume":"52","author":"Sulahian","year":"2014","journal-title":"J Clin Microbiol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12890-018-0614-8","article-title":"Serum (1-3)-\u03b2-D-glucan and galactomannan levels in patients with cystic fibrosis: a retrospective cohort study.","volume":"18","author":"Tr\u00e4ger","year":"2018","journal-title":"BMC Pulm Med"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1128\/JCM.02497-16","article-title":"Usefulness of two aspergillus PCR assays and aspergillus galactomannan and \u03b2-d-Glucan testing of bronchoalveolar lavage fluid for diagnosis of chronic pulmonary aspergillosis.","volume":"55","author":"Urabe","year":"2017","journal-title":"J Clin Microbiol"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"102871","DOI":"10.1016\/j.amjoto.2020.102871","article-title":"The values of (1,3)-\u03b2-D-glucan and galactomannan in cases of invasive fungal rhinosinusitis.","volume":"42","author":"Wei","year":"2020","journal-title":"Am J Otolaryngol"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/myc.12787","article-title":"Performance of serum (1,3)-\u00df-d-glucan screening for the diagnosis of invasive aspergillosis in neutropenic patients with haematological malignancies.","volume":"61","author":"Furfaro","year":"2018","journal-title":"Mycoses"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1164\/rccm.201111-1978OC","article-title":"A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients.","volume":"186","author":"Blot","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2288-3-25","article-title":"The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews.","volume":"3","author":"Whiting","year":"2003","journal-title":"BMC Med Res Methodol"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies.","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jclinepi.2005.02.022","article-title":"Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews.","volume":"58","author":"Reitsma","year":"2005","journal-title":"J Clin Epidemiol"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/bimj.201700101","article-title":"Bivariate random-effects meta-analysis models for diagnostic test accuracy studies using arcsine-based transformations.","volume":"60","author":"Negeri","year":"2018","journal-title":"Biom J"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1080\/10543406.2016.1226328","article-title":"Statistical evaluation of drug efficacy for bridging study in companion diagnostic test trials.","volume":"26","author":"Bu","year":"2016","journal-title":"J Biopharm Stat"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/bmj.323.7305.157","article-title":"Systematic reviews in health care: systematic reviews of evaluations of diagnostic and screening tests.","volume":"323","author":"Deeks","year":"2001","journal-title":"BMJ"},{"key":"R37-20250504","article-title":"The role of oxidative stress and the effects of antioxidants on the incidence of infectious complications of chronic lymphocytic leukemia.","volume":"158135","author":"Gaman","year":"2014","journal-title":"Oxid Med Cell Longev"},{"key":"R38-20250504","first-page":"3486","article-title":"Crosstalk between oxidative stress, chronic inflammation and disease progression in essential thrombocythemia.","volume":"70","author":"Gman","year":"2019","journal-title":"Revista de Chimie -Bucharest- Original Edition-"},{"key":"R39-20250504","first-page":"CD007394","article-title":"Galactomannan detection for invasive aspergillosis in immunocompromised patients.","volume":"2015","author":"Leeflang","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jmii.2014.06.009","article-title":"A systematic review and meta-analysis of diagnostic accuracy of serum 1,3-\u03b2-D-glucan for invasive fungal infection: focus on cutoff levels.","volume":"48","author":"He","year":"2015","journal-title":"J Microbiol Immunol Infect"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"S233","DOI":"10.1080\/13693780802308454","article-title":"Role of (1-->3)-beta-D-glucan in the diagnosis of invasive aspergillosis.","volume":"47","author":"Marty","year":"2009","journal-title":"Med Mycol"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.diagmicrobio.2018.08.005","article-title":"The performance of galactomannan in combination with 1,3-\u03b2-D-glucan or aspergillus-lateral flow device for the diagnosis of invasive aspergillosis: evidences from 13 studies.","volume":"93","author":"Zhang","year":"2019","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0895-4356(03)00177-X","article-title":"The diagnostic odds ratio: a single indicator of test performance.","volume":"56","author":"Glas","year":"2003","journal-title":"J Clin Epidemiol"},{"key":"R44-20250504","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.2169\/internalmedicine.50.6175","article-title":"Diagnosis of invasive fungal disease using serum (1\u21923)-\u03b2-D-glucan: a bivariate meta-analysis.","volume":"50","author":"Lu","year":"2011","journal-title":"Intern Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037067","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T03:20:58Z","timestamp":1746328858000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,2]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000037067","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,2]]}}}